ASHG News

Reaffirming Our Commitment to Diversity, Equity, Inclusion, and Accessibility

Cultivating diversity, equity, inclusion, and accessibility (DEIA) is a guiding priority of ASHG. By championing these values, we maintain our vision that “people everywhere realize the benefits of human genetics and genomics research.” At the Board Meeting in November, the Board approved transitioning the Diversity, Equity, and Inclusion Task Force to the Diversity, Equity, Inclusion... Read More

ASHG Board of Directors

Board Roundup: Fall 2024

The ASHG Board of Directors met on November 4-5 in Denver, CO, to review ASHG’s finances, obtain key program updates, and discuss continued implementation of the Society’s strategic plan. The Board approved several recommendations to advance the Society in key areas, including the annual meeting, Board governance, Diversity, Equity, Inclusion and Accessibility efforts, scientific publishing... Read More

Washington Update: Post-Election Outcomes and Impacts to Biomedical Research

Washington Update: Post-Election Outcomes and Impacts to Biomedical Research

Just a few days after winning the election, the incoming Trump Administration began to identify key health policy proposals. Some of these priorities include addressing mental health issues and tackling the opioid overdose crisis, accelerating translational research, and improving rural health. The National Institutes of Health (NIH) remains under scrutiny, with ongoing discussions surrounding its... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy